146 related articles for article (PubMed ID: 31955909)
21. Immunohistochemical localization of dopamine D2 receptor in the rat carotid body.
Wakai J; Takayama A; Yokoyama T; Nakamuta N; Kusakabe T; Yamamoto Y
Acta Histochem; 2015 Oct; 117(8):784-9. PubMed ID: 26272445
[TBL] [Abstract][Full Text] [Related]
22. Peripheral oxytocin treatment affects the rat adreno-medullary catecholamine content modulating expression of vesicular monoamine transporter 2.
Jovanovic P; Spasojevic N; Stefanovic B; Bozovic N; Jasnic N; Djordjevic J; Dronjak S
Peptides; 2014 Jan; 51():110-4. PubMed ID: 24239562
[TBL] [Abstract][Full Text] [Related]
23. Dopamine beta-hydroxylase-like immunoreactivity in the rat and cat carotid body: a light and electron microscopic study.
Chen IL; Hansen JT; Yates RD
J Neurocytol; 1985 Feb; 14(1):131-44. PubMed ID: 3925090
[TBL] [Abstract][Full Text] [Related]
24. Effects of oxytocin on adreno-medullary catecholamine synthesis, uptake and storage in rats exposed to chronic isolation stress.
Jovanovic P; Stefanovic B; Spasojevic N; Puskas N; Dronjak S
Endocr Res; 2016 May; 41(2):124-31. PubMed ID: 26726927
[TBL] [Abstract][Full Text] [Related]
25. Different subcellular distributions of the vesicular monoamine transporter, VMAT2, in subclasses of sympathetic neurons.
Headley DB; Suhan NM; Horn JP
Brain Res; 2007 Jan; 1129(1):156-60. PubMed ID: 17156758
[TBL] [Abstract][Full Text] [Related]
26. Ontogeny of vesicular monoamine transporter mRNAs VMAT1 and VMAT2. II. Expression in neural crest derivatives and their target sites in the rat.
Hansson SR; Mezey E; Hoffman BJ
Brain Res Dev Brain Res; 1998 Sep; 110(1):159-74. PubMed ID: 9733958
[TBL] [Abstract][Full Text] [Related]
27. [Involvement of vesicular monoamine transporter in attention deficit hyperactivity disorder].
Lorenzo-Sanz G; Sánchez-Herranz A
Rev Neurol; 2011 Mar; 52 Suppl 1():S103-8. PubMed ID: 21365590
[TBL] [Abstract][Full Text] [Related]
28. Differential expression of catecholamine synthetic enzymes in the caudal ventral pons.
Goodchild AK; Phillips JK; Lipski J; Pilowsky PM
J Comp Neurol; 2001 Oct; 438(4):457-67. PubMed ID: 11559901
[TBL] [Abstract][Full Text] [Related]
29. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat.
Weihe E; Schäfer MK; Erickson JD; Eiden LE
J Mol Neurosci; 1994; 5(3):149-64. PubMed ID: 7654518
[TBL] [Abstract][Full Text] [Related]
30. Vesicular monoamine transporters expression in pheochromocytomas and paragangliomas according to scintigraphy and positron emission tomography behavior.
Bacca A; Pucci A; Lorenzini D; Chiacchio S; Volterrani D; Ferrari M; Sellari Franceschini S; Materazzi G; Basolo F; Bernini G
Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):396-401. PubMed ID: 35133098
[TBL] [Abstract][Full Text] [Related]
31. Expression of the two isoforms of the vesicular monoamine transporter (VMAT1 and VMAT2) in the endocrine pancreas and pancreatic endocrine tumors.
Anlauf M; Eissele R; Schäfer MK; Eiden LE; Arnold R; Pauser U; Klöppel G; Weihe E
J Histochem Cytochem; 2003 Aug; 51(8):1027-40. PubMed ID: 12871984
[TBL] [Abstract][Full Text] [Related]
32. Ganglion cells immunoreactive for catecholamine-synthesizing enzymes, neuropeptide Y and vasoactive intestinal polypeptide in the rat adrenal gland.
Oomori Y; Okuno S; Fujisawa H; Iuchi H; Ishikawa K; Satoh Y; Ono K
Cell Tissue Res; 1994 Feb; 275(2):201-13. PubMed ID: 7906614
[TBL] [Abstract][Full Text] [Related]
33. Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.
Hussain I; Bate GW; Henry J; Djali P; Dimaline R; Dockray GJ; Varro A
J Physiol; 1999 Jun; 517 ( Pt 2)(Pt 2):495-505. PubMed ID: 10332097
[TBL] [Abstract][Full Text] [Related]
34. Co-expression studies of the orphan carrier protein Slc10a4 and the vesicular carriers VAChT and VMAT2 in the rat central and peripheral nervous system.
Burger S; Döring B; Hardt M; Beuerlein K; Gerstberger R; Geyer J
Neuroscience; 2011 Oct; 193():109-21. PubMed ID: 21742018
[TBL] [Abstract][Full Text] [Related]
35. Transmitter diversity in carotid body afferent neurons: dopaminergic and peptidergic phenotypes.
Finley JC; Polak J; Katz DM
Neuroscience; 1992 Dec; 51(4):973-87. PubMed ID: 1283213
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of vesicular monoamine transporter (VMAT) 1 and 2 in gastrointestinal endocrine tumours.
Jakobsen AM; Andersson P; Saglik G; Andersson E; Kölby L; Erickson JD; Forssell-Aronsson E; Wängberg B; Ahlman H; Nilsson O
J Pathol; 2001 Nov; 195(4):463-72. PubMed ID: 11745679
[TBL] [Abstract][Full Text] [Related]
37. Norepinephrine-containing glomus cells in the rabbit carotid body. II. Immunocytochemical evidence of dopamine-beta-hydroxylase and norepinephrine.
Schamel A; Verna A
J Neurocytol; 1992 May; 21(5):353-62. PubMed ID: 1607879
[TBL] [Abstract][Full Text] [Related]
38. Genes for human catecholamine-synthesizing enzymes.
Nagatsu T
Neurosci Res; 1991 Oct; 12(2):315-45. PubMed ID: 1684650
[TBL] [Abstract][Full Text] [Related]
39. Sclerosing Paragangliomas: Correlations of Histological Features with Patients' Genotype and Vesicular Monoamine Transporter Expression.
Pucci A; Bacca A; Barravecchia I; Di Stefano I; Belgio B; Lorenzini D; Torregrossa L; Chiacchio S; Congregati C; Materazzi G; Ferrari M; Angeloni D; Bernini G; Basolo F
Head Neck Pathol; 2022 Dec; 16(4):998-1011. PubMed ID: 35524772
[TBL] [Abstract][Full Text] [Related]
40. Catecholamine-synthesizing enzymes in the rat stomach.
Bäck N; Ahonen M; Soinila S; Kivilaakso E; Kiviluoto T
Histochem Cell Biol; 1995 Jul; 104(1):63-7. PubMed ID: 7584561
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
